Savior Lifetec (4167) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Savior Lifetec (4167) has a cash flow conversion efficiency ratio of -0.026x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-98.65 Million ≈ $-3.11 Million USD) by net assets (NT$3.78 Billion ≈ $119.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4167 company net worth for the company's overall valuation and market capitalisation.
Savior Lifetec - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how Savior Lifetec's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Savior Lifetec Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Savior Lifetec ranked by their cash flow conversion efficiency. Explore Savior Lifetec (4167) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Formosa Oilseed Processing Co Ltd
TW:1225
|
-0.011x |
|
IM Vinaria Purcari SRL
RO:WINE
|
0.027x |
|
Bank Yudha Bhakti Tbk
JK:BBYB
|
0.020x |
|
Josef Manner & Comp. AG
VI:MAN
|
-0.119x |
|
HARIM Co. Ltd
KQ:136480
|
0.021x |
|
Autosports Group Ltd
AU:ASG
|
0.043x |
|
Studio City International Holdings Ltd
NYSE:MSC
|
0.015x |
|
Oriental Interest Bhd
KLSE:5827
|
0.016x |
Annual Cash Flow Conversion Efficiency for Savior Lifetec (2011–2025)
The table below shows the annual cash flow conversion efficiency of Savior Lifetec from 2011 to 2025. View latest Savior Lifetec stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | NT$3.78 Billion ≈ $119.12 Million |
NT$-21.04 Million ≈ $-662.91K |
-0.006x | -103.77% |
| 2024-12-31 | NT$3.52 Billion ≈ $110.78 Million |
NT$518.38 Million ≈ $16.33 Million |
0.147x | +27.87% |
| 2023-12-31 | NT$3.36 Billion ≈ $106.01 Million |
NT$387.95 Million ≈ $12.22 Million |
0.115x | -33.27% |
| 2022-12-31 | NT$3.37 Billion ≈ $106.08 Million |
NT$581.77 Million ≈ $18.33 Million |
0.173x | +440.04% |
| 2021-12-31 | NT$3.31 Billion ≈ $104.37 Million |
NT$-168.34 Million ≈ $-5.30 Million |
-0.051x | -285.45% |
| 2020-12-31 | NT$3.33 Billion ≈ $104.92 Million |
NT$91.25 Million ≈ $2.87 Million |
0.027x | -61.21% |
| 2019-12-31 | NT$2.21 Billion ≈ $69.75 Million |
NT$156.40 Million ≈ $4.93 Million |
0.071x | +169.06% |
| 2018-12-31 | NT$1.86 Billion ≈ $58.47 Million |
NT$-189.84 Million ≈ $-5.98 Million |
-0.102x | -184.82% |
| 2017-12-31 | NT$2.16 Billion ≈ $68.15 Million |
NT$260.89 Million ≈ $8.22 Million |
0.121x | +435.93% |
| 2016-12-31 | NT$2.12 Billion ≈ $66.77 Million |
NT$-76.09 Million ≈ $-2.40 Million |
-0.036x | +86.25% |
| 2015-12-31 | NT$1.59 Billion ≈ $50.15 Million |
NT$-415.82 Million ≈ $-13.10 Million |
-0.261x | -265.61% |
| 2014-12-31 | NT$1.29 Billion ≈ $40.75 Million |
NT$-92.41 Million ≈ $-2.91 Million |
-0.071x | -16.66% |
| 2013-12-31 | NT$1.39 Billion ≈ $43.93 Million |
NT$-85.39 Million ≈ $-2.69 Million |
-0.061x | +65.70% |
| 2012-12-31 | NT$1.27 Billion ≈ $40.16 Million |
NT$-227.59 Million ≈ $-7.17 Million |
-0.179x | +48.89% |
| 2011-12-31 | NT$1.31 Billion ≈ $41.38 Million |
NT$-458.82 Million ≈ $-14.46 Million |
-0.349x | -- |
About Savior Lifetec
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, mero… Read more